hapabapa Summary Following my coverage on Zillow Group (NASDAQ:ZG) in Feb’24, which I recommended a buy rating as ZG continued to show very strong performance in all segments and, most importantly, was winning a lot of market share, this post is to provide an update on my thoughts on the business and stock. I still…
luismmolina Investment Overview Immatics (NASDAQ:IMTX), based in Tuebingen, Germany, achieved its Nasdaq listing in 2020, via a business combination with Arya Sciences Acquisition Corp, a special purpose acquisition company (SPAC) sponsored by Perceptive Advisors. According to Harvard Business Review: A SPAC is a publicly traded corporation with a two-year life span formed with the sole…
marketlan/iStock via Getty Images Written by Sam Kovacs Introduction Since suggesting buying Verizon (NYSE:VZ) in February, the stock has gone… nowhere. That is fine by me, I’m in no rush. Good things take time. Verizon just reported its earnings for the 1st quarter of 2024. Its results were mostly in-line, with EPS of $1.15 beating…
2d illustrations and photos/iStock via Getty Images It’s quite understandable for some investors to feel fatigued from a seemingly never-ending buzz about AI. Dotcom era-like obsession of media with everything related to “artificial intelligence” has already led to hyped expectations in the tech sector. This April, however, we clearly see a hangover, with many AI-related…
Hinterhaus Productions monday.com (NASDAQ:MNDY) is an Israeli company providing cloud-based no-code / low-code platform aimed towards team project management. Since going public in 2021 at a price of $189, share performance has been underwhelming. Briefly after reaching an all-time high of $379 towards the end of 2021, MNDY saw a gradual decline and hit the…
JHVEPhoto/iStock Editorial via Getty Images Overview In an environment of rising costs across the board, people are looking for ways to save money any way that they can. Food continues to be an area where a large portion of Americans continue to feel the impact of the price increases. Wendy’s (NASDAQ:WEN) and other fast food…
Charday Penn/E+ via Getty Images It has been over 4 years since my last CRISPR Therapeutics (NASDAQ:CRSP) article when I was hesitant about gathering a heavy CRSP position due to the ticker’s premium valuation, volatility, and the company’s young pipeline. Yet, I was optimistic about the company’s prospects of their expansive pipeline, and partnerships. Despite…
William_Potter IRM’s Growth Catalysts My last article gave Iron Mountain (NYSE:IRM) a sell rating, and the goal of this article is to upgrade the rating to hold. The key reason for the upgrade is the next growth catalysts that have developed since then. IRM has enjoyed robust earnings growth in recent years as seen in…
Dmitry Presnyakov/iStock Editorial via Getty Images Elevator Pitch My investment rating for Geely Automobile Holdings Limited (OTCPK:GELYF) (OTCPK:GELYY) [175:HK] is a Buy. The company’s most recent fiscal year financial results beat expectations, with its earnings exceeding the consensus projection by +7%. Looking forward, I see multiple re-rating catalysts for the stock relating to future sales…
Rick Kern/Getty Images Entertainment We’re nearly through the first quarter of 2024, and likely very few investors would have anticipated the sharp rise in the stock market since the start of the year. My appetite for risk-taking has taken off again, lifting everything from AI stocks to cryptocurrencies. But against this backdrop, investors should focus…
da-kuk The iShares India 50 ETF (NASDAQ:INDY) is performing well, but has already come a long way in the last 12 months and is approaching the all-time high of $53.83. With two major drivers in focus – the election in May and the Reserve Bank of India shifting to a more dovish stance – the…
bauhaus1000/iStock Unreleased via Getty Images Goodyear Tire & Rubber Co. (NASDAQ:GT) is an iconic American tire company, and it is also well known for its blimps. The company offers tires under the Goodyear brand, as well as under the Dunlop and Kelly brand names. The shares recently plunged after the company released earnings, and it…
banjongseal324/iStock via Getty Images Editas Medicine, Inc. (NASDAQ:EDIT) is gearing up for several inflection points in 2024, and I believe that if positive outcomes are achieved for all of them, then that would mean an increase in value for the company and its shareholders. In particular, there are two lead programs that are being advanced…
Rasi Bhadramani/iStock via Getty Images Silence Therapeutics (NASDAQ:SLN) is gearing up to report topline 36-week data from its phase 2 ALPACAR-360 study, which is using its drug zerlasiran [formerly known as SLN360] for the treatment of patients with high lipoprotein[a] and stable atherosclerotic cardiovascular disease [ASCVD]. It is expected to release such data in Q1…
Gary Hershorn/Corbis News via Getty Images Thesis Microsoft Corporation (NASDAQ:MSFT) is my largest individual holding that I continue to buy on every dip opportunity. Microsoft has done extremely well over the last decade, and I believe that next decade is likely to yield similar results. There are several catalysts to support this thesis, including the…
Alexander Farnsworth/iStock via Getty Images In November 2023, I wrote about Caribou Biosciences (NASDAQ:CRBU), rating it a buy based on the data with its off the shelf CAR-T therapeutic CB-010, from which I expected more positive data in 2024, its pipeline and plentiful cash. CRBU is up just 9% since then, despite positive updates and…
Shawn Williams/iStock Editorial via Getty Images Elevator Pitch My investment rating for Samsonite International S.A. (OTCPK:SMSOF) [1910:HK] stays as a Buy. I previously wrote about Samsonite International’s Q1 2021 performance and full-year fiscal 2021 business prospects in an article published on June 17, 2021. The focus of the current write-up is Samsonite International’s near-term financial…
metamorworks Elevator Pitch I continue to award a Buy investment rating to Keyence Corporation (OTCPK:KYCCF) [6861:JP]. My prior write-up published on October 2, 2023 drew attention to the potential for an increase in Keyence’s future dividend payout ratio and the company’s focus on the long run. With this latest article, I focus on a key…
peshkov Welcome back to the third edition of Bank Buzz, where we cover the community bank sector, with a specific focus on mutual conversions, our favorite niche within a niche. Historically, investments in banks trading below tangible book value with overcapitalized balance sheets, solid asset quality, and shareholder-friendly management teams have generated attractive returns. In…
panida wijitpanya Axsome (NASDAQ:AXSM) has been a bellwether of a stock for many investors. After a poor couple of years starting around 2020, when the FDA wasn’t being on the same page with it vis-a-vis the approval of Auvelity, things have really taken a turn for the better after Auvelity’s approval and its extremely bullish…
Jovanmandic/iStock via Getty Images Vistagen Therapeutics (NASDAQ:VTGN) has made great progress in being able to advance its pipeline. That’s because it was able to achieve positive results from its phase 3 PALISADE-2 study, which used its lead drug fasedienol for the treatment of patients with social anxiety disorder [SAD]. Not only was the primary endpoint…
Iurii Garmash Franklin Resources (NYSE:BEN) is a cheap stock by most traditional metrics. BEN trades at just 12.4x forward earnings and currently yields 4.2%. However, I do not generally view a cheap valuation alone as a sufficient reason to buy a stock. Instead, I prefer to see additional upside catalysts combined with an attractive valuation….
vm Hims & Hers Health (NYSE:HIMS) has seen the stock snapback with the company continuing to report strong quarterly results and improved profits. The online health and wellness platform is also moving into AI based medical services along with a push into crucial weight loss management considering the soaring costs of related medicine. My investment…
onurdongel/E+ via Getty Images At the beginning of the year, we wrote an article on Geberit AG (OTC:GBERF) (OTCPK:GBERY) arguing that temporary headwinds had created a buying opportunity in this high-quality business. Since then shares have delivered a total return of roughly 12.5%, outperforming the SPDR EURO STOXX 50 ETF (FEZ) by more than 5%,…
nycshooter The Boeing Company (NYSE:BA)’s shares went into a massive new up-leg after the company presented earnings for its third fiscal quarter at the end of October and the current rally has enough steam to last well into 2024, in my opinion. The aircraft manufacturer’s order books are full and the U.S. economy is performing…
The Sandbox introduces CATALYST tokens on Polygon, replacing gems in NFT minting. These ERC-1155 tokens enable users to mint, monetize, and sell creations, enhancing platform capabilities. In a significant move within the metaverse, The Sandbox introduces CATALYSTs, ERC-1155 tokens aimed at empowering creators. These tokens enable users to mint ASSETs with defined rarity and properties…
designer491 Investment action I recommended a hold rating for BILL Holdings, Bill.com, (NYSE:BILL) when I wrote about it the last time, as I remained uncertain about BILL’s operating performance. In hindsight, the decision to stay on the sidelines was a smart move, as the stock fell by more than 50% since my last update. Based…
Love Employee/iStock via Getty Images Topline Summary Immix Biopharma (NASDAQ:IMMX) is a biotech company focused on development of novel CAR-T and other cell-based therapies for cancers and heme disorders. They are joining a growing group of companies using natural killer cell-based immunotherapy, which remains promising but unproven. Still, IMMX has a bit more data than…
AUNG MYO HTWE/iStock via Getty Images Investment Overview: Zentalis Believes ‘Pipeline-In-A-Pill” Azenosertib Will Soon Make Grade In Ovarian Cancer Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) is a clinical-stage biotech headquartered in New York that was listed on the Nasdaq in April 2020, raising ~$165m via the issuance of ~9.2m shares priced at $18 per share. At the…
Robert Way Undervalued companies can stay undervalued for far longer than we realize. This is a difficult-to-swallow truth, I know. When we identify a potentially undervalued company after conducting thorough research and investing in it at seemingly attractive prices, it is easy to be disheartened when the stock price goes nowhere over a long period….
Nudphon Phuengsuwan Amid a broad market rally over the past few weeks, investors are now wondering: is it too late to get a jump on stocks again? In my view, the answer is no: but the key to beating the markets through next year will be to double down on high-quality small cap stocks that…
Feverpitched Dear readers, eXp World Holdings (NASDAQ:EXPI) is a real estate brokerage with a very interesting business model which allows for significantly lower overhead and faster scalability than virtually all of its peers. Historically, the company has traded like a tech stock, i.e. at a very high P/E ratio, which is the main reason why…
Jacob Boomsma/iStock via Getty Images Elevator Pitch Alexander & Baldwin, Inc. (NYSE:ALEX) shares continue to warrant a Buy investment rating. With my prior May 22, 2023 article, I highlighted the major growth drivers for ALEX in the long run. I identify a number of re-rating catalysts that are likely to be realized for Alexander &…
DanielBendjy Graham Corporation (NYSE:GHM) recently delivered beneficial expectations about 2024, including EBITDA growth and net sales growth. GHM is also expected to benefit significantly from recent increases in defense budgets. Besides, management also says that it may reposition its efforts to enjoy the incoming expenditures in the clear energy market. There are obvious risks from…
Yijing Liu Short-term catalyst ahead Tencent Holdings (OTCPK:TCEHY), the world’s leading game publisher, is strategically positioning its esports division in anticipation of the Hangzhou Asian Games scheduled for September 23 to October 8, 2023. Asian Games, also known as Asiad, is a continental multi-sport event held every fourth year among athletes from all over Asia….
wwing Introduction Crew Energy Inc. (OTCQB:CWEGF) is a Canadian gas-oriented producer that we last wrote up with a strong buy in the low $3’s in February, noting however the macro environment for gas might make growth difficult over the short haul. That’s still true, but there are some catalysts with a 3-6 month timeline that…
powerofforever/iStock via Getty Images After taking the stock to “Strong Buy” in May, GEO Group (NYSE:GEO) has continued to underperform. Let’s catch up on the name. Company Profile As a refresher, GEO owns, leases, and manages detention facilities. Its operations are primarily in the U.S., but it also serves facilities in Australia and South Africa…
Pgiam/iStock via Getty Images Investment updates Since the last publication, shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) have failed to catch a bid and pushed further to the downside. I rated RARE a speculative buy in February, and after a short snapback rally, it sold off quickly following its Q2 numbers and amid the broad selloff…
gahsoon Phillips Edison (NASDAQ:PECO), owner and operator of grocery-anchored shopping centers, turned in another record quarter in Q2. The records were attained in both leased rates and renewal spreads. The latter is being sustained by ferocious demand for their property class. New rent spreads, for example, are being completed at over 20% rates. In my…
SDI Productions/E+ via Getty Images Exelixis (NASDAQ:EXEL) has made great progress in advancing its drug known as CABOMETYX for the treatment of several types of cancer. It has already been able to receive approval of this drug for the treatment of patients with kidney cancer, liver cancer and thyroid cancer. However, why I believe it…
sankai Investment Rundown The share price has been volatile for Ambarella Inc (NASDAQ:AMBA) as the semiconductor industry is facing a difficult economic environment, not as enriched with demand as it previously was. As companies are managing to stock up inventories more efficiently, the sudden demand and shortages for some products in the industry seem to…
BalkansCat/iStock Editorial via Getty Images Introduction Getinge AB (OTCPK:GNGBY) is a Swedish Healthcare Medical Tech company focusing on three revenue segments: Acute Care, Life Sciences, and Surgical Workflows. The company is small, valued at a $5 billion USD market cap, but offers a leading position across multiple unique niches within its target markets. This includes…
RichVintage Introduction This article builds on prior signal event articles with more explanations on how to benefit some of our efforts. As more data points are collected, more insights are gained. The last Momentum Memo discussed the strong June 1 Momentum Gauge breakout signal that has led to the longest positive run of the year….